搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
8 天
on MSN
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.
3 天
on MSN
Global medical technology firm shifts some of its San Diego manufacturing to Tijuana
CareFusion, a BD subsidiary, is conducting layoffs as well as moving some of its engineering and manufacturing jobs to other ...
3 天
Thousands of patients reliant on IV nutrition face shortages from Helene, CVS
Hurricane Helene wrecked a factory in North Carolina that produced 60% of the fluids their sustenance is mixed from.
Interesting Engineering on MSN
11 天
Cardiovascular breakthrough: Nanoparticle therapy cuts plaque buildup in arteries
Researchers at Michigan State University have developed a new nanotherapy infusion for the treatment of arterial plaque ...
8 天
on MSN
Injectable drug to ease advanced Parkinson's disease symptoms approved by FDA
The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...
McKnight's Long-Term Care News
6 天
A new treatment option gets FDA approval for adults with advanced Parkinson’s disease
The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...
8 天
Video shows remarkable improvements for Parkinson's patient after new infusion drug
A patient who received a new infusion therapy treatment for Parkinson’s disease showed progress after just two days, Sherwood Forest Hospitals said.
MarketWatch
8 天
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
said Thursday the Food and Drug Administration has approved its vyalev as the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor ...
News Medical on MSN
7 天
Helene and CVS land double whammy for 25,000 patients who survive on IV nutrition
Although the FDA is allowing emergency imports of IV fluids wiped out by Helene, as well as production of some of the fluids ...
STAT
2 天
How to make sure opioid settlement money isn’t wasted
Opinion: More than $55 billion in opioid settlement money has flowed into state, county, and city coffers. Much of it is at ...
Franchise Times
12 小时
Senior Care Franchises Fuel Fast-Growing Health & Medical Segment
While the makeup of the Franchise Times Top 400 Health & Medical category is changing, with regenerative therapy, mental ...
9 小时
Intellia Therapeutics: Lower Stock Price On HAE Data Presents A Buying Opportunity
Positive results for Intellia Therapeutics, Inc.'s NTLA-2002 in treating HAE patients. Stock price dips, but the program ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈